PARP9-PARP13-PARP14 axis tunes colorectal cancer response to radiotherapy
Abstract Background Colorectal cancer (CRC) is the third most prevalent cancer worldwide. Despite substantial advancements in CRC therapy in recent years, ionizing radiation (IR) continues to be the predominant treatment for colon malignances. However, it still lacks the precision required for excel...
Saved in:
| Main Authors: | Rimvile Prokarenkaite, Karolina Kuodyte, Greta Gudoityte, Elzbieta Budginaite, Daniel Naumovas, Egle Strainiene, Kristijonas Velickevicius, Audrius Dulskas, Ernestas Sileika, Jonas Venius, Virginijus Tunaitis, Augustas Pivoriunas, Vytaute Starkuviene, Vaidotas Stankevicius, Kestutis Suziedelis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Journal of Experimental & Clinical Cancer Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13046-025-03439-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the radiochemistry of PARP inhibitors: a new era in therapy and imaging
by: Gianluca Destro, et al.
Published: (2025-07-01) -
PARP9 and PARP14 are involved in microglia-mediated neuroinflammation in Alzheimer′s disease
by: HUANG Lian, WEI Hui
Published: (2025-05-01) -
Specific and shared biological functions of PARP2 – is PARP2 really a lil’ brother of PARP1?
by: Magdolna Szántó, et al.
Published: (2024-01-01) -
PARP enzymes and mono-ADP-ribosylation: advancing the connection from interferon-signalling to cancer biology
by: Barbara Morone, et al.
Published: (2024-01-01) -
The role of Poly-ADP ribose polymerase (PARP) enzymes in chemotherapy-induced cognitive impairments – parallels with other neurodegenerative disorders
by: Dahlia A. Ordaz, et al.
Published: (2025-06-01)